{
    "Trade/Device Name(s)": [
        "Hevylite Human IgM Kappa Kit for use on SPAPLUS",
        "Hevylite Human IgM Lambda Kit for use on SPAPLUS"
    ],
    "Submitter Information": "The Binding Site Group Ltd",
    "510(k) Number": "K140686",
    "Predicate Device Reference 510(k) Number(s)": [
        "K113823"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PDE",
        "PDF"
    ],
    "Summary Letter Date": "July 04, 2014",
    "Summary Letter Received Date": "July 07, 2014",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5510"
    ],
    "Regulation Name(s)": [
        "Immunoglobulins A, G, M, D, and E immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "IgM Kappa",
        "IgM Lambda"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "Binding Site SPAPLUS"
    ],
    "Method(s)/Technology(ies)": [
        "Turbidimetry"
    ],
    "Methodologies": [
        "Antigen-antibody reaction",
        "Light scatter measurement"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Hevylite Human IgM Kappa and Lambda turbidimetric quantification kits for use on SPAPLUS platform",
    "Indications for Use Summary": "In vitro quantification of IgM kappa and IgM lambda in human serum for patients with previously diagnosed Waldenstr\u00f6m\u2019s macroglobulinaemia, to be used in conjunction with other clinical and laboratory findings; not established for diagnosis, monitoring, or prognosis of Waldenstr\u00f6m\u2019s macroglobulinaemia",
    "fda_folder": "Immunology"
}